Iduna Fichtner

University of Milan — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

55h-index10.1kcitations406works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Research and Treatments(43), Nanoparticle-Based Drug Delivery(38), RNA Interference and Gene Delivery(30), Cancer Genomics and Diagnostics(30), Lung Cancer Treatments and Mutations(24)

Publications406 total

Extracellular vesicles characterization in patients with hypertrophic cardiomyopathy
European Heart Journal·2024
Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing
Cancers·2023· 5 citedOpen Access
GIPC1 regulates MACC1-driven metastasis
Frontiers in Oncology·2023· 1 citedOpen Access
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures
Frontiers in Oncology·2023· 22 citedOpen Access
Supplementary Figure Legend from Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB
2023Open Access
Supplementary Data from Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer
2023Open Access
Supplementary Tables 1 - 8 from Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB
2023Open Access
Supplementary Figures 1 - 13 from Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB
2023Open Access
Supplementary Data from Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
2023Open Access
Supplementary Figure Legend from Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB
2023Open Access
Data from Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer
2023Open Access
Supplementary Methods from Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB
2023Open Access
Supplementary Data from Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
2023Open Access
Figure S1-S5 from Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP
2023Open Access
Supplementary Methods from Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB
2023Open Access
Data from Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB
2023Open Access
Data from Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP
2023Open Access
Supplementary Tables 1 - 8 from Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB
2023Open Access
Supplementary Data from Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figures 1 - 13 from Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Ulrike Stein(8), Felix Kratz(8), Wolfgang Walther(7), M Lemm(7), Peter M. Schlag(5), Michael W. Becker(5), André Warnecke(4), Peter Kufer(4), Patrick A. Baeuerle(4), Janice Smith(3), Walter Birchmeier(3), Jana Rolff(3), N. Esser(3), Clemens Unger(3), Bernd Schlereth(3), Ulrike Sack(3), Dennis Kobelt(3), Robert H. Shoemaker(3), Jutta Aumann(3), Franziska Arlt(2)